| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent
|
Kodama, Itsuo
|
|
1999
|
84 |
9S1 |
p. 20-28
9 p.
|
artikel
|
| 2 |
Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization
|
Singh, Bramah N
|
|
1999
|
84 |
9S1 |
p. 161-173
13 p.
|
artikel
|
| 3 |
Beta-adrenergic blocker mortality trials in congestive heart failure
|
Teerlink, John R
|
|
1999
|
84 |
9S1 |
p. 94-102
9 p.
|
artikel
|
| 4 |
Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the grupo de estudio de la sobrevida en la insuficiencia cardiaca en Argentina (GESICA)
|
Doval, Hernan C
|
|
1999
|
84 |
9S1 |
p. 109-114
6 p.
|
artikel
|
| 5 |
Class III drugs and congestive heart failure: focus on the congestive heart failure-survival trial of antiarrhythmic therapy
|
Singh, Steven N
|
|
1999
|
84 |
9S1 |
p. 103-108
6 p.
|
artikel
|
| 6 |
Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations
|
Pollak, P.Timothy
|
|
1999
|
84 |
9S1 |
p. 37-45
9 p.
|
artikel
|
| 7 |
Concomitant device and drug therapy: current trends, potential benefits, and adverse interactions
|
Marchlinski, Francis E
|
|
1999
|
84 |
9S1 |
p. 69-75
7 p.
|
artikel
|
| 8 |
Efficacy and safety of septal and left-atrial linear ablation for atrial fibrillation
|
Jaı̈s, Pierre
|
|
1999
|
84 |
9S1 |
p. 139-146
8 p.
|
artikel
|
| 9 |
Epidemiology and significance of atrial fibrillation
|
Ryder, Kathryn M
|
|
1999
|
84 |
9S1 |
p. 131-138
8 p.
|
artikel
|
| 10 |
Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions
|
Nattel, Stanley
|
|
1999
|
84 |
9S1 |
p. 11-19
9 p.
|
artikel
|
| 11 |
Evolution of diagnostic and interventional cardiac electrophysiology: a brief historical review
|
Feld, Gregory K
|
|
1999
|
84 |
9S1 |
p. 115-124
10 p.
|
artikel
|
| 12 |
Implantable defibrillators and antiarrhythmic drugs in patients at risk for lethal arrhythmias
|
Zivin, Adam
|
|
1999
|
84 |
9S1 |
p. 63-68
6 p.
|
artikel
|
| 13 |
Implantable devices versus antiarrhythmic drug therapy in recurrent ventricular tachycardia and ventricular fibrillation
|
Hohnloser, Stefan H
|
|
1999
|
84 |
9S1 |
p. 56-62
7 p.
|
artikel
|
| 14 |
Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias
|
Kudenchuk, Peter J
|
|
1999
|
84 |
9S1 |
p. 52-55
4 p.
|
artikel
|
| 15 |
Intravenous antiarrhythmic regimens with focus on amiodarone for prophylaxis of atrial fibrillation after open heart surgery
|
Guarnieri, Thomas
|
|
1999
|
84 |
9S1 |
p. 152-155
4 p.
|
artikel
|
| 16 |
Intravenous antiarrhythmic therapy in the acute control of in-hospital destabilizing ventricular tachycardia and fibrillation
|
Kowey, Peter R
|
|
1999
|
84 |
9S1 |
p. 46-51
6 p.
|
artikel
|
| 17 |
Introduction
|
Singh, Bramah N
|
|
1999
|
84 |
9S1 |
p. 1-2
2 p.
|
artikel
|
| 18 |
Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs
|
Yap, Yee Guan
|
|
1999
|
84 |
9S1 |
p. 83-89
7 p.
|
artikel
|
| 19 |
Mechanisms of atrial fibrillation and flutter and implications for management
|
Chen, Peng-Sheng
|
|
1999
|
84 |
9S1 |
p. 125-130
6 p.
|
artikel
|
| 20 |
Mechanisms underlying variability in response to drug therapy: implications for amiodarone use
|
Roden, Dan M
|
|
1999
|
84 |
9S1 |
p. 29-36
8 p.
|
artikel
|
| 21 |
Meta-analysis of antiarrhythmic drug trials
|
Connolly, Stuart J
|
|
1999
|
84 |
9S1 |
p. 90-93
4 p.
|
artikel
|
| 22 |
Mortality reduction by antiadrenergic modulation of arrhythmogenic substrate: significance of combining beta blockers and amiodarone
|
Ogunyankin, Kofo O
|
|
1999
|
84 |
9S1 |
p. 76-82
7 p.
|
artikel
|
| 23 |
Overview of trends in the control of cardiac arrhythmia: past and future
|
Singh, Bramah N
|
|
1999
|
84 |
9S1 |
p. 3-10
8 p.
|
artikel
|
| 24 |
Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation
|
Van Gelder, Isabelle C
|
|
1999
|
84 |
9S1 |
p. 147-151
5 p.
|
artikel
|
| 25 |
Prevention of atrial fibrillation in the postoperative cardiac patient: significance of oral class III antiarrhythmic agents
|
Morady, Fred
|
|
1999
|
84 |
9S1 |
p. 156-160
5 p.
|
artikel
|
Tijdschrift beschrijving